DD292263A5 - Verfahren zur herstellung neuer assoziate der hyaluronsaeure - Google Patents

Verfahren zur herstellung neuer assoziate der hyaluronsaeure Download PDF

Info

Publication number
DD292263A5
DD292263A5 DD90338061A DD33806190A DD292263A5 DD 292263 A5 DD292263 A5 DD 292263A5 DD 90338061 A DD90338061 A DD 90338061A DD 33806190 A DD33806190 A DD 33806190A DD 292263 A5 DD292263 A5 DD 292263A5
Authority
DD
German Democratic Republic
Prior art keywords
solution
hyaluronate
zinc
hyaluronic acid
sodium
Prior art date
Application number
DD90338061A
Other languages
German (de)
English (en)
Inventor
Kalman Burger
Geza T Nagy
Ivan Rethey
Janos Illes
Bela Stefko
Erzsebet Neszmelyi
Istvan Gebhardt
Istvan Racz
Gyoengyver Kiraly
Viktoria Varkonyi
Original Assignee
�������@���@��������@������@�K@�Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@���@��������@������@�K@�Kk�� filed Critical �������@���@��������@������@�K@�Kk��
Publication of DD292263A5 publication Critical patent/DD292263A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DD90338061A 1989-02-24 1990-02-22 Verfahren zur herstellung neuer assoziate der hyaluronsaeure DD292263A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU89891A HU203372B (en) 1989-02-24 1989-02-24 Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient

Publications (1)

Publication Number Publication Date
DD292263A5 true DD292263A5 (de) 1991-07-25

Family

ID=10951903

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90338061A DD292263A5 (de) 1989-02-24 1990-02-22 Verfahren zur herstellung neuer assoziate der hyaluronsaeure

Country Status (33)

Country Link
US (1) US5554598A (fr)
EP (1) EP0413016B1 (fr)
JP (1) JP2571312B2 (fr)
KR (1) KR960015624B1 (fr)
CN (2) CN1024557C (fr)
AR (1) AR243538A1 (fr)
AT (1) ATE98964T1 (fr)
AU (1) AU623232B2 (fr)
BG (1) BG61515B2 (fr)
CA (1) CA2027596C (fr)
CZ (1) CZ281000B6 (fr)
DD (1) DD292263A5 (fr)
DE (1) DE69005394T2 (fr)
DK (1) DK0413016T3 (fr)
ES (1) ES2061016T3 (fr)
FI (1) FI101707B (fr)
GE (2) GEP19981358B (fr)
GR (1) GR1000869B (fr)
HK (1) HK1003003A1 (fr)
HU (2) HU203372B (fr)
IE (1) IE62408B1 (fr)
IL (1) IL93489A (fr)
LT (2) LT3806B (fr)
LV (2) LV10112B (fr)
MY (1) MY105168A (fr)
NO (1) NO301169B1 (fr)
PL (1) PL163417B1 (fr)
PT (1) PT93237B (fr)
RU (2) RU2099350C1 (fr)
SK (1) SK279530B6 (fr)
UA (2) UA26324A (fr)
WO (1) WO1990010020A1 (fr)
ZA (1) ZA901357B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR920100122A (el) * 1991-04-05 1993-03-16 Ethicon Inc Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως.
DE4115454A1 (de) * 1991-05-11 1992-11-12 Basf Ag Eisen-(iii)-hyaluronate
US5531716A (en) * 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
IT1273742B (it) * 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
CN1064372C (zh) * 1994-08-26 2001-04-11 顾其胜 透明质酸钠制剂的制备方法
US6368356B1 (en) 1996-07-11 2002-04-09 Scimed Life Systems, Inc. Medical devices comprising hydrogel polymers having improved mechanical properties
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
US6869938B1 (en) 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US7192984B2 (en) 1997-06-17 2007-03-20 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use as dermal fillers
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
JP2003089647A (ja) * 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
US6566345B2 (en) 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US6913765B2 (en) 2001-03-21 2005-07-05 Scimed Life Systems, Inc. Controlling resorption of bioresorbable medical implant material
CZ12015U1 (cs) * 2002-01-18 2002-02-25 Cpn Spol. S R.O. Přípravek pro prevenci adheze bandáľe na ránu
RU2220729C2 (ru) * 2002-01-31 2004-01-10 Общество с ограниченной ответственностью "Научный Центр системных исследований и технологий 2000" Гелевая композиция, используемая в стоматологии
US8461410B2 (en) 2002-09-11 2013-06-11 Ethicon, Inc. Wound dressing materials comprising complexes of anionic polysaccharides with silver
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
RU2227742C1 (ru) * 2002-09-25 2004-04-27 Представительство фирмы "Гедеон Рихтер" на Волге Средство для профилактики послеоперационного спаечного процесса
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
RU2280041C1 (ru) * 2005-04-21 2006-07-20 Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия ЛТД" Способ получения водорастворимых солевых комплексов гиалуроновой кислоты (варианты)
JPWO2006121210A1 (ja) * 2005-05-13 2008-12-18 高田製薬株式会社 皮膚状態改善剤
JPWO2006121209A1 (ja) * 2005-05-13 2008-12-18 高田製薬株式会社 湿疹・皮膚炎群治療剤
JP4220513B2 (ja) * 2005-12-01 2009-02-04 株式会社資生堂 カチオン化ヒアルロン酸
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
FR2918565B1 (fr) * 2007-07-12 2009-10-30 Biopharmex Holding Sa Hydrogel de carboxyalkylamide de chitosan, sa preparation et son utilisation cosmetique et dermatologique
ES2326721B1 (es) * 2008-01-04 2010-07-16 Endor Nanotechnologies, S.L. Conjugado de acido hialuronico para el tratamiento cosmetico y procedimiento de preparacion.
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
JP5728865B2 (ja) 2010-01-07 2015-06-03 株式会社リコー 放熱機構、及び放熱板の支え金具
CN102834417B (zh) * 2010-04-14 2015-11-25 丘比株式会社 透明质酸金属盐的制造方法、包含透明质酸金属盐的化妆品的制造方法以及透明质酸锌及其制造方法
ES2376680B8 (es) 2010-08-16 2013-04-30 Nylstar, S.A. Fibra textil cosmética, procedimiento de obtención y su empleo.
CN102552309B (zh) * 2010-12-15 2013-06-05 北京理工大学 一种透明质酸金的用途及其制备方法
JP5763953B2 (ja) * 2011-03-31 2015-08-12 ロート製薬株式会社 外用組成物
CN102961396A (zh) * 2012-12-17 2013-03-13 程玉李 透明质酸金属盐在制备治疗皮肤病药物中的应用、其药物组合物及其制备方法
US10449254B2 (en) 2013-11-03 2019-10-22 The Regents Of The University Of California Ionic liquids for transdermal drug delivery
JP6608620B2 (ja) * 2015-05-26 2019-11-20 ロート製薬株式会社 皮膚外用剤
CA3035414C (fr) * 2016-08-29 2022-02-22 The Regents Of The University Of California Formulations topiques a base d'especes ioniques pour le traitement de la peau
KR20190070327A (ko) 2016-09-21 2019-06-20 네슬레 스킨 헬스 소시에떼 아노님 2가 아연 양이온을 갖는 히알루론산 겔
WO2019001784A1 (fr) 2017-06-28 2019-01-03 Nestlé Skin Health Sa Gel d'acide hyaluronique avec un cation divalent
HUE066356T2 (hu) 2017-08-24 2024-07-28 Novo Nordisk As GLP-1 készítmények és alkalmazásaik
PE20221575A1 (es) 2020-02-18 2022-10-06 Novo Nordisk As Formulaciones farmaceuticas
CN111647100B (zh) * 2020-07-14 2022-03-01 山东华熙海御生物医药有限公司 一种高分子量透明质酸锌的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US441973A (en) 1890-12-02 rapieff
US3074927A (en) * 1960-04-12 1963-01-22 Paul D Saltman Metallic complexes of reducing sugars
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
HU172831B (hu) * 1976-03-31 1978-12-28 Egyt Gyogyszervegyeszeti Gyar Sposob poluchenija kompleksov oligo- i poligalakturonnyk kislot s ionami zhiznenno vazhnykh metallov
US4303676A (en) 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
IT1229075B (it) 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
US4623539A (en) * 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
NO161573C (no) 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
JPS61286310A (ja) * 1985-06-10 1986-12-16 Kanebo Ltd メ−クアツプ化粧料
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
EP0259485A4 (fr) * 1986-03-14 1988-07-29 Bio Technology General Corp Sels de metaux lourds de l'acide hyaluronique utiles en tant qu'agents antimicrobiens.
US4742215A (en) * 1986-05-07 1988-05-03 Personal Computer Card Corporation IC card system
EP0356435B1 (fr) * 1987-03-19 1995-10-18 Arthropharm Pty. Limited Composes et compositions anti-inflammatoires

Also Published As

Publication number Publication date
HU211465A9 (en) 1995-11-28
UA39174C2 (uk) 2001-06-15
GEP19971015B (en) 1997-05-30
LT3806B (en) 1996-03-25
PT93237A (pt) 1990-08-31
KR960015624B1 (ko) 1996-11-18
SK85790A3 (en) 1998-12-02
GR1000869B (el) 1993-03-16
FI101707B1 (fi) 1998-08-14
LV10112A (lv) 1994-05-10
FI905109A0 (fi) 1990-10-17
IE62408B1 (en) 1995-01-25
EP0413016A1 (fr) 1991-02-20
DE69005394D1 (de) 1994-02-03
LV10112B (en) 1995-02-20
LV10965B (en) 1996-08-20
AR243538A1 (es) 1993-08-31
CA2027596C (fr) 2001-01-02
ZA901357B (en) 1990-11-28
FI101707B (fi) 1998-08-14
EP0413016B1 (fr) 1993-12-22
CN1051228C (zh) 2000-04-12
LTIP1418A (en) 1995-05-25
ATE98964T1 (de) 1994-01-15
CA2027596A1 (fr) 1990-08-25
MY105168A (en) 1994-08-30
CZ281000B6 (cs) 1996-05-15
UA26324A (uk) 1999-08-30
ES2061016T3 (es) 1994-12-01
DE69005394T2 (de) 1994-07-28
AU623232B2 (en) 1992-05-07
CZ85790A3 (en) 1995-02-15
SK279530B6 (sk) 1998-12-02
CN1045394A (zh) 1990-09-19
JPH03505231A (ja) 1991-11-14
NO301169B1 (no) 1997-09-22
IE900637L (en) 1990-08-24
DK0413016T3 (da) 1994-02-14
PL163417B1 (pl) 1994-03-31
WO1990010020A1 (fr) 1990-09-07
KR920700231A (ko) 1992-02-19
NO904584D0 (no) 1990-10-23
LTIP1474A (en) 1995-06-26
AU5108890A (en) 1990-09-26
US5554598A (en) 1996-09-10
PT93237B (pt) 1996-01-31
LV10965A (lv) 1995-12-20
IL93489A (en) 1994-05-30
RU2021304C1 (ru) 1994-10-15
LT3873B (en) 1996-04-25
RU2099350C1 (ru) 1997-12-20
BG61515B2 (bg) 1997-10-31
GEP19981358B (en) 1998-08-25
PL283942A1 (en) 1991-01-28
NO904584L (no) 1990-12-21
HK1003003A1 (en) 1998-09-30
JP2571312B2 (ja) 1997-01-16
CN1024557C (zh) 1994-05-18
CN1086422A (zh) 1994-05-11
HUT53128A (en) 1990-09-28
GR900100137A (en) 1991-06-28
HU203372B (en) 1991-07-29

Similar Documents

Publication Publication Date Title
DE69005394T2 (de) Zusammensetzungen welche komplexe von hyaluronsäure enthalten und verfahren zu deren herstellung.
EP0000133B1 (fr) Préparations pharmaceutiques contenant des polysaccharides on polymères sulfatés et des ions de zinc pour l'application topique dans les infections virales.
DE69732049T2 (de) Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika
EP1455803B2 (fr) Utilisation du panthenol et/ou d'acide pantothénique ou d'acide hyaluronique et/ou de hyaluronate pour la manufacture d'une composition pharmaceutique pour une utilisation ophtalmologique
DE69932313T2 (de) Wässerige flüssige zubereitungen
DE69317444T2 (de) Antivirale topische pharmazeutische zusammensetzungen
DE69116184T2 (de) Topisch anwendbare Zusammensetzungen auf der Basis von hoch molekularer Hyaluronsäure zur Behandlung von Entzündungen der Mundhöhle, zu deren Hygiene und kosmetischer Behandlung
DE3734835A1 (de) Arzneimittel zur ophthalmologischen anwendung
EP0135617B1 (fr) Onguent gélatineux contenant de l'indométhacine
EP0801948A1 (fr) Composition ophtalmique à temps de sejour prolongé
EP0012115A1 (fr) Préparations pharmaceutiques pour le traitement topique d'infections virales
CH685099A5 (de) Pharmazeutisches Präparat für die intranasale Anwendung.
DE69302396T2 (de) Antiviral wirksame pharmazeutische öl in wasser-emulsion, die 9-[(2-hydroxyethoxy)methyl]-guanin (acyclovir) oder ein salz oder einen ester davon enthält
DE69320968T2 (de) Neue bioaktive zusammensetzungen, ihre herstellung und verwendung
DE2918799A1 (de) Ophthalmische loesung
DE2731648A1 (de) Sulfadiazinsalze von seltenen erdmetallen und thorium, insbesondere cersulfadiazin, verfahren zu ihrer herstellung und ihre verwendung zur lokalen behandlung von verbrennungen
DE2639505B2 (fr)
DE3882042T2 (de) Antiallergische augentropfen.
DE602004006024T2 (de) Pharmazeutische zusammensetzung mit einem zink/hyaluronat-komplex zur behandlung von multipler sklerose
EP0294538B1 (fr) Emploi de nigericine dans la production d'un médicament pour le traitement des maladies virales
DE3787274T2 (de) Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.
DE69613803T2 (de) Augentropfen insbesonders zur Behandlung des trockenen Auges
DE3750248T2 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
DE10360425A1 (de) Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung
US5472950A (en) Compositions containing cobalt hyaluronic acid complex

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee